Qingbo Huang

2.1k citations
83 papers · 1.4k indexed · h-index 22
Topics
Renal cell carcinoma treatment (41 papers)Renal and related cancers (24 papers)Vascular anomalies and interventions (10 papers)

In The Last Decade

Qingbo Huang

72 papers receiving 1.3k citations

Peers

Qingbo Huang
Comparison fields: 5 of 110
  • Molecular Biology 779
  • Pulmonary and Respiratory Medicine 620
  • Cancer Research 466
  • Surgery 257
  • Oncology 154
Replace Cheng Liu with:
Cheng Liu China
Wen Kong China
Jiandong Zhang China
Willem E. Hellings Netherlands
Hidenori Kage Japan
Giorgio Melloni United States
Randolph Hutter United States
Luyang Zhang China
Hyun Chang South Korea
Qingbo Huang relative to Cheng Liu China Cheng Liu's profile →
Citations per field
00.5×3.3×
Cheng Liu · 1×
Citations per year

Countries citing papers authored by Qingbo Huang

Since Specialization
Citations

This map shows the geographic impact of Qingbo Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbo Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbo Huang more than expected).

Fields of papers citing papers by Qingbo Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingbo Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbo Huang. The network helps show where Qingbo Huang may publish in the future.

Co-authorship network of co-authors of Qingbo Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingbo Huang. A scholar is included among the top collaborators of Qingbo Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingbo Huang. Qingbo Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 6
5 1
6 1
7 3
8 1
9 2
10 15
11 16
12 4
13
Bandwidth Extension Method Based on Generative Adversarial Nets for Audio Compression
1
14 9
15 67
16 63
17 4
18
[Relationship between self-rated filial piety and depressive symptoms among the elderly].
4
19 50
20 21

About Qingbo Huang

Qingbo Huang is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Cancer Research, having authored 83 papers that have together received 1.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (41 papers), Renal and related cancers (24 papers) and Vascular anomalies and interventions (10 papers). The work is most often cited by research in Cancer Research (466 citations), Pulmonary and Respiratory Medicine (620 citations) and Molecular Biology (779 citations). Qingbo Huang has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Xin Ma, Yu Gao, Xintao Li, Hongzhao Li, Xu Zhang, Liangyou Gu, Xu Zhang, Baojun Wang, Qing Ai and Chawnshang Chang. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026